Neovasc Announces Second Quarter 2018 Financial Results Conference Call and Webcast
NASDAQ, TSX: NVCN
VANCOUVER, Aug. 2, 2018 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, today announced that it will report financial results for the quarter and six months ended June 30, 2018 and host a conference call and webcast at 4:30pm Eastern Time on Wednesday, August 8, 2018.
| Conference Call & Webcast |
|
| Wednesday, August 8th @ 4:30pm Eastern Time |
|
| Domestic: |
888-254-3590 |
| International: |
323-994-2093 |
| Passcode: |
9226007 |
| Webcast: |
|
| Replays available through August 22nd: |
|
| Domestic: |
844-512-2921 |
| International: |
412-317-6671 |
| Conference ID: |
9226007 |
About Neovasc Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ (the "Reducer"), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara™ (the "Tiara"), for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States , Canada and Europe . For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.
Chris Clark, Chief Financial Officer, Neovasc Inc., 604 248-4138, [email protected]; Jeremy Feffer, LifeSci Advisors, LLC, 212-915-2568
Share this article